UK NanoKTN counts 3,000th member, courts stronger bioscience interest
This article was originally published in Clinica
The UK’s Nanotechnology Knowledge Transfer Network (NanoKTN) is celebrating its 3,000th member. The government-backed initiative, which was established to support the exploitation and commercialisation of micro and nanotechnology (MNT) generally, is designed to provide a forum linking the MNT R&D sector with the wider industry through collaborations between suppliers and users. Its Healthcare & Life Sciences group boasts 270 members, and the network is seeking to attract further interest in the bioscience and other sectors of this industry, a spokesperson told Clinica. Earlier this year, the NanoKTN unveiled plans to set up a medtech-specific Nanotechnology in Medical Devices (NiMeD) focus group (www.clinica.co.uk, 1 March 2012).
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.